Skip to main content

Want a detailed portfolio tracker?

Pluri (PLUR) P/E (2011 - 2026)

Pluri (PLUR) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM Pluri (PLUR) P/E is -0.68. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pluri (PLUR)

YearP/EChange
2026-0.68-28.89%
2025-0.96-17.87%
2024-1.16+35.43%
2023-0.86+8.67%
2022-0.79-11.64%
2021-0.90-80.51%
2020-4.59+155.70%
2019-1.80-44.40%
2018-3.23-27.26%
2017-4.44-13.20%
2016-5.12+32.64%
2015-3.86-38.17%
2014-6.24-28.96%
2013-8.78+5.89%
2012-8.30-36.00%
2011-12.96N/A

Comparison Pluri (PLUR) P/E with competitors

Pluri (PLUR) P/E is -0.68.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.25%
NBYStablecoin Development Corp0.00-100.63%
ENLVEnlivex Ltd0.07-111.00%
FGENFibroGen Inc0.24-135.29%
CHRSCoherus Biosciences Inc0.85-224.75%
FBIOFortress Biotech Inc0.95-239.53%
ORMPOramed Pharmaceuticals Inc1.50-320.98%
AGENAgenus Inc3.01-542.47%
INVAInnoviva Inc3.15-563.70%
VXRTVaxart Inc3.55-621.88%
CRMDCorMedix Inc3.63-633.45%
CVACCureVac N.V.4.45-753.60%
GLPGGalapagos NV4.86-814.35%
SRPTSarepta Therapeutics Inc4.88-817.76%
ABEOAbeona Therapeutics Inc5.39-892.07%
ABUSArbutus Biopharma Corp5.60-922.67%
ZVRAZevra Therapeutics Inc5.89-965.54%
SPROSpero Therapeutics Inc6.23-1015.70%
CGENCompugen Ltd6.31-1028.27%
RIGLRigel Pharmaceuticals6.87-1110.33%
SLXNSilexion Therapeutics Corp7.30-1172.67%
OMEROmeros Corporation9.26-1461.22%
AUPHAurinia Pharmaceuticals Inc9.58-1509.18%
ACADAcadia Pharmaceuticals Inc11.73-1824.33%
TBPHTheravance Biopharma Inc12.26-1902.78%
ADMAAdma Biologics Inc12.42-1925.72%
HRMYHarmony Biosciences Holdings Inc13.82-2131.85%
SABSSAB Biotherapeutics Inc14.14-2178.31%
NAGENiagen Bioscience Inc14.82-2278.56%
INCYIncyte Corp15.82-2426.24%
REGNRegeneron Pharmaceuticals Inc15.86-2431.25%
PBYIPuma Biotechnology Inc17.32-2645.76%
CPRXCatalyst Pharmaceuticals Inc17.44-2663.93%
EXELExelixis Inc17.54-2678.44%
TGTXTG Therapeutics Inc18.97-2888.40%
MDXGMimedx Group Inc20.55-3121.64%
XOMAXOMA Royalty Corp22.87-3463.13%
ARGXArgen X SE24.30-3672.39%
CTMXCytomX Therapeutics Inc24.82-3749.30%
XOMAOXOMA Royalty Corp25.34-3826.30%
HALOHalozyme Therapeutics Inc25.62-3867.31%
XOMAPXOMA Royalty Corp25.67-3874.13%
VRTXVertex Pharmaceuticals Inc27.99-4215.90%
RPRXRoyalty Pharma plc - Class A28.69-4317.76%
SLNOSoleno Therapeutics Inc29.02-4365.96%
ASNDAscendis Pharma A/S30.09-4523.30%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5673.98%
APLSApellis Pharmaceuticals Inc39.02-5837.06%
BMRNBiomarin Pharmaceutical Inc42.21-6306.16%
KRYSKrystal Biotech Inc45.34-6766.59%
ONCBeiGene Ltd69.54-10324.13%
PHARPharming Group N.V.75.03-11130.58%
TECHBio-Techne Corp101.96-15090.36%
VCELVericel Corp109.92-16261.11%
ALNYAlnylam Pharmaceuticals Inc117.96-17443.74%
GMABGenmab140.29-20726.15%
TLXTelix Pharmaceuticals Ltd162.15-23940.41%
CORTCorcept Therapeutics Inc212.86-31395.23%